Found: 113
Select item for more details and to access through your institution.
Effect of alisertib, an investigational aurora a kinase inhibitor on the QTc interval in patients with advanced malignancies.
- Published in:
- Investigational New Drugs, 2018, v. 36, n. 2, p. 240, doi. 10.1007/s10637-017-0498-0
- By:
- Publication type:
- Article
Effects of rifampin, itraconazole and esomeprazole on the pharmacokinetics of alisertib, an investigational aurora a kinase inhibitor in patients with advanced malignancies.
- Published in:
- Investigational New Drugs, 2018, v. 36, n. 2, p. 248, doi. 10.1007/s10637-017-0499-z
- By:
- Publication type:
- Article
Hereditary inclusion body myopathy: single patient response to GNE gene Lipoplex therapy.
- Published in:
- Journal of Gene Medicine, 2010, v. 12, n. 5, p. 403, doi. 10.1002/jgm.1450
- By:
- Publication type:
- Article
Down-regulation of pancreatic and duodenal homeobox-1 by somatostatin receptor subtype 5: a novel mechanism for inhibition of cellular proliferation and insulin secretion by somatostatin.
- Published in:
- Frontiers in Physiology, 2014, v. 5, p. 1, doi. 10.3389/fphys.2014.00226
- By:
- Publication type:
- Article
Down-regulation of pancreatic and duodenal homeobox-1 by somatostatin receptor subtype 5: a novel mechanism for inhibition of cellular proliferation and insulin secretion by somatostatin.
- Published in:
- Frontiers in Physiology, 2014, v. 5, p. 1, doi. 10.3389/fphys.2014.00226
- By:
- Publication type:
- Article
KRAS mutant allele-specific expression knockdown in pancreatic cancer model with systemically delivered bi-shRNA KRAS lipoplex.
- Published in:
- PLoS ONE, 2018, v. 13, n. 6, p. 1, doi. 10.1371/journal.pone.0193644
- By:
- Publication type:
- Article
Shedding New Light on the Use of Imaging Technology for Glioblastoma Tumor Resection.
- Published in:
- Molecular Therapy, 2015, v. 23, n. 7, p. 1136, doi. 10.1038/mt.2015.98
- By:
- Publication type:
- Article
Pilot Trial of FANG Immunotherapy in Ewing's Sarcoma.
- Published in:
- Molecular Therapy, 2015, v. 23, n. 6, p. 1103, doi. 10.1038/mt.2015.43
- By:
- Publication type:
- Article
Phase 1 Trial of Bi-shRNA STMN1 BIV in Refractory Cancer.
- Published in:
- Molecular Therapy, 2015, v. 23, n. 6, p. 1123, doi. 10.1038/mt.2015.14
- By:
- Publication type:
- Article
Phase I Study of a Systemically Delivered p53 Nanoparticle in Advanced Solid Tumors.
- Published in:
- Molecular Therapy, 2013, v. 21, n. 5, p. 1096, doi. 10.1038/mt.2013.32
- By:
- Publication type:
- Article
Case Report: Marked Survival Advantage of Two Colorectal Cancer Patients with Liver Metastases Treated with Vigil and FOLFOX-6.
- Published in:
- 2021
- By:
- Publication type:
- Case Study
Long-Term Follow-Up of Gemogenovatucel-T (Vigil) Survival and Molecular Signals of Immune Response in Recurrent Ovarian Cancer.
- Published in:
- Vaccines, 2021, v. 9, n. 8, p. 894, doi. 10.3390/vaccines9080894
- By:
- Publication type:
- Article
Resident Memory T Cells and Their Effect on Cancer.
- Published in:
- Vaccines, 2020, v. 8, n. 4, p. 562, doi. 10.3390/vaccines8040562
- By:
- Publication type:
- Article
Analysis of Adenoviral p53 Gene Therapy Clinical Trials in Recurrent Head and Neck Squamous Cell Carcinoma.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2021.645745
- By:
- Publication type:
- Article
Interleukin 10-Mediated Response and Correlated Anemia in a Patient with Advanced Non-Small Cell Lung Carcinoma.
- Published in:
- Case Reports in Oncology, 2019, v. 12, n. 1, p. 297, doi. 10.1159/000499704
- By:
- Publication type:
- Article
Nucleic acid aptamers for targeting of shRNAbased cancer therapeutics.
- Published in:
- Biologics: Targets & Therapy, 2007, v. 1, n. 4, p. 367
- By:
- Publication type:
- Article
Targeted Combination of Poly(ADP-ribose) Polymerase Inhibitors and Immune Checkpoint Inhibitors Lacking Evidence of Benefit: Focus in Ovarian Cancer.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 6, p. 3173, doi. 10.3390/ijms25063173
- By:
- Publication type:
- Article
Ovarian Cancer Immunotherapy and Personalized Medicine.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 12, p. 6532, doi. 10.3390/ijms22126532
- By:
- Publication type:
- Article
Randomized placebo-controlled trial of granulocyte-macrophage colony-stimulating-factor support for dose-intensive cyclophosphamide, etoposide, and cisplatin.
- Published in:
- American Journal of Hematology, 1996, v. 51, n. 4, p. 289, doi. 10.1002/(SICI)1096-8652(199604)51:4<289::AID-AJH7>3.0.CO;2-S
- By:
- Publication type:
- Article
Granulocyte-macrophage colony-stimulating factor gene-modified autologous tumor vaccines in non-small-cell lung cancer.
- Published in:
- 2004
- By:
- Publication type:
- journal article
3D engineered scaffold for large-scale Vigil immunotherapy production.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-65993-3
- By:
- Publication type:
- Article
Procoagulant inhibitory properties of paclitaxel poliglumex.
- Published in:
- International Journal of General Medicine, 2011, v. 4, p. 5, doi. 10.2147/IJGM.S12170
- By:
- Publication type:
- Article
Chimeric Antigen Receptor T-Cell Therapy: Reach to Solid Tumor Experience.
- Published in:
- Oncology, 2019, v. 97, n. 2, p. 59, doi. 10.1159/000500488
- By:
- Publication type:
- Article
Summary of bi-shRNA/GM-CSF Augmented Autologous Tumor Cell Immunotherapy (FANG™) in Advanced Cancer of the Liver.
- Published in:
- Oncology, 2014, v. 87, n. 1, p. 21, doi. 10.1159/000360993
- By:
- Publication type:
- Article
A Phase I Study of Telomerase-specific Replication Competent Oncolytic Adenovirus (Telomelysin) for Various Solid Tumors.
- Published in:
- Molecular Therapy, 2010, v. 18, n. 2, p. 429, doi. 10.1038/mt.2009.262
- By:
- Publication type:
- Article
943. Prognostic Determinants Associated with Efficacy of Adenoviral p53 Gene Therapy in Patients with Recurrent Squamous Cell Carcinoma of the Head and Neck.
- Published in:
- Molecular Therapy, 2006, v. 13, p. S364, doi. 10.1016/j.ymthe.2006.08.1034
- By:
- Publication type:
- Article
1023. New Generation of shRNA for Targeted Cancer Gene Therapy.
- Published in:
- Molecular Therapy, 2006, v. 13, p. S393, doi. 10.1016/j.ymthe.2006.08.1118
- By:
- Publication type:
- Article
1104. Phase II Study of Lucanix™ a Transforming Growth Factor β2 (TGF-β2) Antisense Gene Modified Allogeneic Tumor Cell Vaccine in Non Small Cell Lung Cancer (NSCLC).
- Published in:
- Molecular Therapy, 2006, v. 13, p. S424, doi. 10.1016/j.ymthe.2006.08.1209
- By:
- Publication type:
- Article
51. Clinical Study of Personalized Therapeutics Based on Genomic/Proteomic Profiling.
- Published in:
- Molecular Therapy, 2006, v. 13, p. S21, doi. 10.1016/j.ymthe.2006.08.066
- By:
- Publication type:
- Article
54. TNFerade™ in Pancreas Cancer: Local Activation with Systemic Potential.
- Published in:
- Molecular Therapy, 2006, v. 13, p. S23, doi. 10.1016/j.ymthe.2006.08.069
- By:
- Publication type:
- Article
52. A Phase 1 Dose-Escalation Trial of Intravesical CG0070 for Superficial Transitional Cell Carcinoma (TCC) of the Bladder after Bacillus Calmette-Guerin (BCG) Failure.
- Published in:
- Molecular Therapy, 2006, v. 13, p. S22, doi. 10.1016/j.ymthe.2006.08.067
- By:
- Publication type:
- Article
276. Phase I Trial of Sequential Administration of Recombinant DNA and Adenovirus Expressing L523S Protein in Early Stage Non Small Cell Lung Cancer (NSCLC).
- Published in:
- Molecular Therapy, 2006, v. 13, p. S106, doi. 10.1016/j.ymthe.2006.08.330
- By:
- Publication type:
- Article
288. Bi-Modality Induction of TNFα: Neoadjuvant Chemoradiotherapy and TNFerade™ in Patients with Locally Advanced, Resectable Esophageal Carcinoma.
- Published in:
- Molecular Therapy, 2006, v. 13, p. S110, doi. 10.1016/j.ymthe.2006.08.343
- By:
- Publication type:
- Article
289. Adenoviral-Mediated p53 Gene Therapy (Advexin) in a Patient with Li-Fraumeni Syndrome with a Mixed Germ Cell Tumor: Tolerability and Response.
- Published in:
- Molecular Therapy, 2006, v. 13, p. S110, doi. 10.1016/j.ymthe.2006.08.344
- By:
- Publication type:
- Article
290. Prolegomenon to a Phase II Study of an ICP34.5/ICP47 Deleted Herpes Simplex Virus Containing the Coding Sequence for GM-CSF in Patients with Melanoma.
- Published in:
- Molecular Therapy, 2006, v. 13, p. S110, doi. 10.1016/j.ymthe.2006.08.345
- By:
- Publication type:
- Article
311. Target-Specific Knockdown and Enhanced Anti-Tumor Outcome by an Oncolytic Virus- Delivered Small Interfering RNA (siRNA).
- Published in:
- Molecular Therapy, 2006, v. 13, p. S118, doi. 10.1016/j.ymthe.2006.08.366
- By:
- Publication type:
- Article
378. Phase I Trial of Intravenous Infusion of Onyx 015 and Enbrel in Solid Tumor Patients.
- Published in:
- Molecular Therapy, 2006, v. 13, p. S144, doi. 10.1016/j.ymthe.2006.08.438
- By:
- Publication type:
- Article
560. GNE Gene Replacement in Hereditary Inclusion Body Myopathy.
- Published in:
- Molecular Therapy, 2006, v. 13, p. S215, doi. 10.1016/j.ymthe.2006.08.633
- By:
- Publication type:
- Article
631. Phase 1/2 Trial of Autologous Tumor Mixed with an Allogeneic GVAX® Immunotherapy in Advanced Stage Non-Small Cell Lung Cancer.
- Published in:
- Molecular Therapy, 2006, v. 13, p. S243, doi. 10.1016/j.ymthe.2006.08.706
- By:
- Publication type:
- Article
630. A Phase 2 Randomized Study of GM-CSF Gene-Modified Autologous Tumor Cell Immunotherapy (CG8123) with and without Low- Dose Cyclophosphamide in Advanced Stage Non- Small Cell Lung Cancer (NSCLC).
- Published in:
- Molecular Therapy, 2006, v. 13, p. S243, doi. 10.1016/j.ymthe.2006.08.705
- By:
- Publication type:
- Article
838. 10 Year Follow-Up of 146 Advanced Stage NSCLC Patients Who Received Adenoviral Based Therapy.
- Published in:
- Molecular Therapy, 2006, v. 13, p. S324, doi. 10.1016/j.ymthe.2006.08.924
- By:
- Publication type:
- Article
Phase I Trial of Sequential Administration of Recombinant DNA and Adenovirus Expressing L523S Protein in Early Stage Non-Small-Cell Lung Cancer.
- Published in:
- Molecular Therapy, 2006, v. 13, n. 6, p. 1185, doi. 10.1016/j.ymthe.2006.01.013
- By:
- Publication type:
- Article
GM-CSF Gene-Transduced Tumor Vaccines
- Published in:
- Molecular Therapy, 2005, v. 12, n. 1, p. 18, doi. 10.1016/j.ymthe.2005.02.012
- By:
- Publication type:
- Article
Fighting Cancer with Vaccinia Virus: Teaching New Tricks to an Old Dog
- Published in:
- Molecular Therapy, 2005, v. 11, n. 2, p. 180, doi. 10.1016/j.ymthe.2004.10.015
- By:
- Publication type:
- Article
Clinical and local biological effects of an intratumoral injection of mda-7 (IL24; INGN 241) in patients with advanced carcinoma: a phase I study
- Published in:
- Molecular Therapy, 2005, v. 11, n. 1, p. 149, doi. 10.1016/j.ymthe.2004.09.019
- By:
- Publication type:
- Article
Intratumoral Injection of INGN 241, a Nonreplicating Adenovector Expressing the Melanoma-Differentiation Associated Gene-7 (mda-7/IL24): Biologic Outcome in Advanced Cancer Patients
- Published in:
- Molecular Therapy, 2005, v. 11, n. 1, p. 160, doi. 10.1016/j.ymthe.2004.09.021
- By:
- Publication type:
- Article
mda-7/IL-24: Exploiting Cancer's Achilles' Heel
- Published in:
- Molecular Therapy, 2005, v. 11, n. 1, p. 4, doi. 10.1016/j.ymthe.2004.08.012
- By:
- Publication type:
- Article
Selective Replicating Viral Vectors: Potential for Use in Cancer Gene Therapy.
- Published in:
- BioDrugs, 2003, v. 17, n. 4, p. 251, doi. 10.2165/00063030-200317040-00004
- By:
- Publication type:
- Article
p53 Gene Replacement for Cancer—Interactions with DNA Damaging Agents.
- Published in:
- Acta Oncologica, 2001, v. 40, n. 6, p. 739, doi. 10.1080/02841860152619160
- By:
- Publication type:
- Article
Notch1 Activation Up-Regulates Pancreatic and Duodenal Homeobox-1.
- Published in:
- Genes, 2013, v. 4, n. 3, p. 358, doi. 10.3390/genes4030358
- By:
- Publication type:
- Article